SCHEMBL19796953

SCHEMBL19796953

C=C(C)C(=O)OCc1cc(CCCCCCC)ccc1-c1ccc(-c2ccc(OCCO)cc2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.46
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SLCO1B3 Q9NPD5 1/20 0.45
SLCO1B1 Q9Y6L6 1/20 0.45
RARA P10276 2/20 0.39
PTPN11 Q06124 1/20 0.39
RARG P13631 1/20 0.39
FFAR4 Q5NUL3 9/20 0.39
S1PR1 P21453 2/20 0.39
S1PR3 Q99500 2/20 0.39
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19796883 0.96 RARB (0.45) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19796789 0.90 RARB (0.50) RARBMEN1ALDH1A1KMT2ARARA
SCHEMBL19796958 0.88 RARB (0.51) RARBMEN1ALDH1A1KMT2ARARA
SCHEMBL19796809 0.88 RARB (0.44) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19796875 0.87 MEN1 (0.47) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19796919 0.87 MEN1 (0.47) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19796948 0.87 MEN1 (0.46) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19624680 0.86 MEN1 (0.43) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19796946 0.86 RARB (0.44) RARBMEN1USP2ALDH1A1LMNA
SCHEMBL19624576 0.86 RARB (0.47) RARBMEN1ALDH1A1KMT2ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 RARB 3517/4885MEN1 1151/4885USP2 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.